Literature DB >> 33878901

Antimicrobial/anticancer peptides: bioactive molecules and therapeutic agents.

Kimia Kardani1,2, Azam Bolhassani1.   

Abstract

Antimicrobial peptides (AMPs) have been known as host-defense peptides. These cationic and amphipathic peptides are relatively short (∼5-50 L-amino acids) with molecular weight less than 10 kDa. AMPs have various roles including immunomodulatory, angiogenic and antitumor activities. Anticancer peptides (ACPs) are a main subset of AMPs as a novel therapeutic approach against tumor cells. The physicochemical properties of the ACPs influence their cell penetration, stability and efficiency of targeting. Up to now, several databases and web servers for in silico prediction of AMPs/ACPs have been established prior to the lab analysis. The present review focuses on the recent advancement about AMPs/ACPs activities including their in silico prediction by computational tools and their potential applications as therapeutic agents especially in cancer.

Entities:  

Keywords:  anticancer peptides; antimicrobial peptides; biological activity; cancer; classification; host-defense peptides; in silico prediction; mechanisms of action; peptide antibiotics; physicochemical properties

Mesh:

Substances:

Year:  2021        PMID: 33878901     DOI: 10.2217/imt-2020-0312

Source DB:  PubMed          Journal:  Immunotherapy        ISSN: 1750-743X            Impact factor:   4.196


  3 in total

1.  Multiple Antimicrobial Effects of Hybrid Peptides Synthesized Based on the Sequence of Ribosomal S1 Protein from Staphylococcus aureus.

Authors:  Sergey V Kravchenko; Pavel A Domnin; Sergei Y Grishin; Alexander V Panfilov; Viacheslav N Azev; Leila G Mustaeva; Elena Y Gorbunova; Margarita I Kobyakova; Alexey K Surin; Anna V Glyakina; Roman S Fadeev; Svetlana A Ermolaeva; Oxana V Galzitskaya
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

Review 2.  Lights and Shadows on the Therapeutic Use of Antimicrobial Peptides.

Authors:  Denise Bellotti; Maurizio Remelli
Journal:  Molecules       Date:  2022-07-18       Impact factor: 4.927

Review 3.  Nanomedicine in Hepatocellular Carcinoma: A New Frontier in Targeted Cancer Treatment.

Authors:  Anita Bakrania; Gang Zheng; Mamatha Bhat
Journal:  Pharmaceutics       Date:  2021-12-25       Impact factor: 6.321

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.